UBS reiterated a Neutral rating on Edgewell Personal Care (NYSE: EPC), and raised the price target to $84.00 (from $79.00), following the company's 1Q earnings report. EPC delivered strong results relative to expectations. The 8c EPS beat, as well as a 3% bump in organic growth, was driven by underlying growth in both N. America and International markets.

Analyst Stephen Powers commented, "EPC delivered strong FYQ1:16 results relative to expectations, driven by underlying growth in both N. America and International markets, as transitional issues (e.g., go-tomarket changes) were less material than anticipated going into the quarter. EPC thus surprised on both the top- and bottom-line, delivering $0.68 in EPS (vs. UBSe of $0.59, cons. of $0.60), and organic growth of roughly +3% (excluding negative go-to-market change impacts) vs. UBSe of -0.5%. 2016 guidance remained largely unchanged with organic growth still expected to be ~flat (including -1.5% go-to market changes), and EPS of $3.20-$3.40 (vs. pre-release cons. of $3.26) with a slightly worsened FX outlook."

For an analyst ratings summary and ratings history on Edgewell Personal Care click here. For more ratings news on Edgewell Personal Care click here.

Shares of Edgewell Personal Care closed at $81.42 yesterday.